1.媒体来源:
CBS NEWS(美国哥伦比亚广播公司:CBS晚间新闻开始播出于1950年，是美国最早
的晚间新闻节目，在美国电视新闻界拥有重要地位。)
2.记者署名:
NATACHA LARNAUD
3.完整新闻标题:
Researchers look into cannabis as a potential COVID-19 treatment
4.完整新闻内文:
As new daily coronavirus infections continue to break records in the U.S.,
researchers are considering whether the cannabis plant has the potential to
be used in the treatment of COVID-19.
随着美国的确诊人数每日打破新纪录，研究者正考虑将大麻用于治疗武汉肺炎
Experts from the University of Nebraska and the Texas Biomedical Research
Institute are recommending that scientists study the anti-inflammatory
properties in CBD as a potential treatment for lung inflammation caused by
the coronavirus.
内布拉斯加州大学和德州生物医学研究所的专家建议，研究CBD中
的抗发炎特性作为治疗冠状病毒引起的肺部炎症的潜在方法。
There is no scientific evidence that cannabis or its compounds can help with
COVID-19 specifically, but in a peer-reviewed article in Brain, Behavior, and
Immunity, the authors said further research is needed to understand if CBD
can help patients infected by the virus.
目前没有明确的证据表明大麻与其化合物对武汉肺炎有明确的效果，
但在【Brain, Behavior, and Immunity】这本期刊里面一篇通过同侪
审查的文章指出，需要更进一步的研究来确定CBD是否可以帮助那些受
到COVID19感染的患者。
Emily Earlenbaugh, a Forbes contributor and co-founder of Mindful Cannabis
Consulting, joined CBSN to discuss the study. She explained that in severe
cases of COVID-19, the body's immune system overreacts and releases too many
cytokines, which is called a "cytokine storm."
"Cytokines will normally help to create inflammation to fight off
infections," Earlenbaugh said. "But in these extreme cases, you see so much
cytokines being released into the system that it creates a cytokine storm.
You might see high fever, inflammation, severe fatigue and nausea, and in
serious cases, it can lead to death through organ failure."
Earlenbaugh said CBD is known from previous research as an IL-6 cytokine
inhibitor, meaning it helps reduce the production of cytokines.
富比世杂志作家、Mindful Cannabis Consulting共同创办人Emily Earlenbaugh
指出，在严重的COVID-19病例中，人体的免疫系统过度反应并释放出过
多的细胞因子，这被称为“细胞因子风暴"，会出现高烧，发炎，严重的
疲劳和恶心，甚至导致器官衰竭而导致死亡。
但在先前的研究指出CBD被称为IL-6细胞因子抑制剂，这意味着它有助于
减少细胞因子的产生。
The authors of the study wrote that one drug, Tocilizumab, resulted in the
"clearance of lung consolidation and recovery" in 90% of the 21 treated
patients. The drug, however, resulted in adverse side effects like pancreas
inflammation and hypertriglyceridemia.
Researchers then turned to cannabis, specifically CBD. The authors said that
several cannabinoids in the cannabis plant have anti-inflammatory properties.
They said CBD "has shown beneficial anti-inflammatory effects in pre-clinical
models of various chronic inflammatory diseases" and noted that the FDA
approved one CBD product to treat certain forms of epilepsy.
研究的作者写到在经过使用一款名叫Tocilizumab的药物来治疗21个病患，
并留下了许多后遗症后，团队开始考虑使用大麻，特别是CBD的部分。作者
表示大麻里数种大麻素都被证明具有抗发炎的特质。
"CBD has very few side effects, so it's something that's being looked at as a
much more mild treatment that still has a lot of anti-inflammatory powers,"
Earlenbaugh told CBSN.
Earlenbaugh告诉CBSN：“ CBD几乎没有副作用，因此它是一种更温和的治
疗方法，且具有非常强大的消炎作用。”
The authors of the study said that CBD can help reduce anxiety in patients
and increase the production of interferons, a protein that helps the body
fight infections.
But given the early stages of this research, Earlenbaugh said she would
"definitely express caution" against using cannabis as a treatment for
COVID-19. She said some researchers have warned using the drug early on in
the infection stages could cause negative side effects.
但有鉴于目前还在研究早期，不建议使用大麻作为治疗手段。
"We're pretty far away from human research that could really definitively
answer those questions for us," Earlenbaugh said. "The other reason for
caution is that cytokines are important in fighting off infections. So, we
don't want to reduce them as a preventative measure or in early stages of the
infection."
5.完整新闻连结 (或短网址):
https://risu.io/9O0J
6.备注:
医用大麻几乎不会爽 制剂更不会
大麻在台湾还是超级违法